Related Experiment Video
Updated: Jul 8, 2026

05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Antiphospholipid syndrome in pregnancy
1rbick@thromosis.com
Hematology/Oncology Clinics of North America
|January 22, 2008
Summary
This study details a cost-effective protocol for evaluating recurrent miscarriages, focusing on thrombosis and hemostasis. The aim is to identify causes and optimize therapy for successful pregnancy outcomes in women with antiphospholipid syndrome.
Area of Science:
- Reproductive Medicine
- Hematology
- Immunology
Background:
- Recurrent miscarriage affects numerous women, often linked to thrombotic and hemostatic disorders.
- Antiphospholipid syndrome is a significant cause of recurrent pregnancy loss.
Purpose of the Study:
- To present a streamlined, cost-effective evaluation protocol for recurrent miscarriage.
- To optimize diagnostic and therapeutic strategies for women with recurrent pregnancy loss and suspected antiphospholipid syndrome.
Main Methods:
- Systematic evaluation of 351 women referred for thrombosis and hemostasis assessment after recurrent miscarriages.
- Description of a specific clinical flow protocol for diagnosis and management.
- Review of treatment outcomes for antiphospholipid syndrome in recurrent miscarriage patients.
Main Results:
- The protocol aims to maximize diagnostic success while minimizing evaluation costs.
- It provides a framework for identifying underlying causes of recurrent miscarriage.
- The study discusses outcomes of the proposed protocol and existing treatments for antiphospholipid syndrome.
Conclusions:
- An optimized evaluation protocol can improve diagnostic yield for recurrent miscarriage.
- Effective management of antiphospholipid syndrome is crucial for successful pregnancy outcomes.
- Cost-effective evaluation is achievable without compromising diagnostic accuracy.
Related Concept Videos
Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...